CCND1 and breast cancer: Moreover, DILA1-ASOs significantly increased ubiquitinated Cyclin D1 in MCF7-Re cells (Fig. 3i), suggesting that DILA1 inhibits the ubiquitination of Cyclin D1 and leads to upregulated Cyclin D1 protein in tamoxifen-resistant breast cancer cells.